Early Reduction of FeNO on Anti-IL5 Biologics Is Associated With Clinical Remission of Severe Asthma. Soendergaard MB, Hansen S, Hakansson KEJ, von Bulow A, et al. Allergy 2024 Dec 14. doi: 10.1111/all.16425.

Read + Share

Amedeo Smart

Independent Medical Education

Soendergaard MB, Hansen S, Hakansson KEJ, von Bulow A, et al. Early Reduction of FeNO on Anti-IL5 Biologics Is Associated With Clinical Remission of Severe Asthma. Allergy 2024 Dec 14. doi: 10.1111/all.16425.
PMID: 39673455